Cargando…

Highlights on molecular targets in the management of COVID-19: Possible role of pharmacogenomics

By the end of 2022, there had been a reduction in new cases and deaths caused by coronavirus disease 2019 (COVID-19). At the same time, new variants of the severe acute respiratory syndrome coronavirus 2 virus were being discovered. Critically ill patients with COVID-19 have been found to have high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thabet, Romany H., Massadeh, Noor A., Badarna, Omar B., Al-Momani, Omar M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893104/ https://www.ncbi.nlm.nih.gov/pubmed/36717541 http://dx.doi.org/10.1177/03000605231153764

Ejemplares similares

Structure–activity relationships andz interindividual variability of drug responses: pharmacogenomics with antimicrobial drugs as a paradigm
por: Thabet, Romany H., et al.
Publicado: (2023)

Pharmacogenomics and migraine: possible implications
por: Tfelt-Hansen, Peer, et al.
Publicado: (2008)

Pharmacogenomics and Molecular Diagnostics
por: Banerjee, Ena Ray
Publicado: (2017)

Pharmacogenomics of COVID-19 therapies
por: Takahashi, Takuto, et al.
Publicado: (2020)

Pharmacogenomics of GPCR Drug Targets
por: Hauser, Alexander S., et al.
Publicado: (2018)

Update on the pharmacogenomics of pain management
por: Kaye, Alan David, et al.
Publicado: (2019)

The Potential Roles of Pharmacists in the Clinical Implementation of Pharmacogenomics
por: Maruf, Abdullah Al, et al.
Publicado: (2023)

Is there a role of pharmacogenomics in Africa
por: Matimba, A., et al.
Publicado: (2016)

The Role of Pharmacogenomics in Opioid Prescribing
por: Wong, Aaron K., et al.
Publicado: (2022)

Pharmacogenomic considerations in the opioid management of pain
por: Jannetto, Paul J, et al.
Publicado: (2010)

Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality
por: AL-Taie, Anmar, et al.
Publicado: (2022)

Physicians' Perspective on Vaccine-Hesitancy at the Beginning of Israel's COVID-19 Vaccination Campaign and Public's Perceptions of Physicians' Knowledge When Recommending the Vaccine to Their Patients: A Cross-Sectional Study
por: Gesser-Edelsburg, Anat, et al.
Publicado: (2022)

Pharmacogenomics
Publicado: (2008)

Pharmacogenomics
Publicado: (2008)

Role of pharmacogenomics in drug discovery and development
por: Surendiran, A., et al.
Publicado: (2008)

Pharmacogenomics of sevoflurane: role in emergence delirium
por: Nair, Abhijit
Publicado: (2019)

A Case for Pharmacogenomics in Management of Cardiac Arrhythmias
por: Kandoi, Gaurav, et al.
Publicado: (2012)

The pharmacogenomics of pain management: prospects for personalized medicine
por: Ting, Sonya, et al.
Publicado: (2016)

Clinical utility of pharmacogenomics in the management of hepatitis C
por: Trinks, Julieta, et al.
Publicado: (2014)

Pharmacogenomics and the Management of Mood Disorders—A Review
por: Kleine Schaars, Kristian, et al.
Publicado: (2023)

Comprehensive Assessment of Indian Variations in the Druggable Kinome Landscape Highlights Distinct Insights at the Sequence, Structure and Pharmacogenomic Stratum
por: Panda, Gayatri, et al.
Publicado: (2022)

Noncoding RNA Roles in Pharmacogenomic Responses to Aspirin: New Molecular Mechanisms for an Old Drug
por: Khazeei Tabari, Mohammad Amin, et al.
Publicado: (2021)

The role of micronutrients in the management of COIVD-19 and optimizing vaccine efficacy
por: Altooq, Noor, et al.
Publicado: (2022)

Role of pharmacogenomics in the treatment of tuberculosis: a review
por: Ramachandran, Geetha, et al.
Publicado: (2012)

Disease burden and the role of pharmacogenomics in African populations
por: Mpye, K. L., et al.
Publicado: (2017)

Pharmacogenomics arrives
por: Petsko, Gregory A
Publicado: (2004)

Pharmacogenomic Biomarkers
por: Kirkwood, Sandra C., et al.
Publicado: (2002)

Pharmacogenomics in epilepsy
por: Balestrini, Simona, et al.
Publicado: (2018)

Pharmacogenomics of Antibiotics
por: Stocco, Gabriele, et al.
Publicado: (2020)

Pharmacogenomics in Practice
por: Wang, Liewei, et al.
Publicado: (2019)

Pharmacogenomics and Morphine
por: Ofoegbu, Adaku, et al.
Publicado: (2021)

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics
por: Mizzi, Clint, et al.
Publicado: (2016)

Pharmacogenomics of acetaminophen in pediatric populations: a moving target
por: Krasniak, Anne E., et al.
Publicado: (2014)

The Implementation Process for Pharmacogenomic Testing for Cancer-Targeted Therapies
por: Wu, Ann Chen, et al.
Publicado: (2018)

Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment
por: Bignucolo, Alessia, et al.
Publicado: (2017)

Pharmacogenomic insights into treatment and management of statin-induced myopathy
por: Peters, Bas JM, et al.
Publicado: (2009)

Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
por: Coons, James C, et al.
Publicado: (2023)

COVID-19 Vaccine: A Possible Trigger for Pyoderma Gangrenosum
por: Mohd, Ahmed B, et al.
Publicado: (2022)

Pharmacogenomics at the post-pandemic: If not now, then when?
por: Al-Mahayri, Zeina N.
Publicado: (2022)

Clinical application of high throughput molecular screening techniques for pharmacogenomics
por: Wiita, Arun P, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bf2df5osp8ftbqjlhuakj7ad8k